2025 annual financial data
Ensysce Biosciences 2025 Net margin
Direct answer
Net margin was -200.84%.
Operating income was -10,240,946 USD and net income was -10,175,700 USD.
Operating cash flow was -7,806,292,000,000 USD.
Get free Ensysce Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 5,066,650 USD
- Operating income
- -10,240,946 USD
- Net income
- -10,175,700 USD
- Operating cash flow
- -7,806,292,000,000 USD